Welcome
Thank you for taking an interest in our work. We hope that you can find what we are looking for, whether you are a colleague scientist, a patient with neurological disease or generally interested. Please do not hesitate to contact us directly.
Currently our work is focused on:
- Improving the availability of data in electonic health records in the UK for MS researchers
- Using real-world data to answer important questions about how best to use MS therapies
- Exploring how best to measure remyelination in adults and children with MS
- Investigating natural remyelination in people with MS
- Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS
Featured News
Remyelination varies markedly within and between lesions
In multiple sclerosis chronic demyelination is associated with axonal loss, and ultimately contributes to irreversible progressive disability. Enhancing remyelination may…
CCMR2 A trial of a possible remyelinating treatment in multiple sclerosis Nerves in the brain and spinal cord are normally…
CCMR2 Trial will start in March 2022
Finally, our trial of metformin and clemastine is ready to start… or it will be when the placebo is manufactured…